Home NDC 68788-9752 cephalexin
Product NDC 68788-9752
11-digit product format 687889752
Labeler code 68788
Product ID 68788-9752_a35fc563-9bf1-4242-92f8-638c6827eba1
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name cephalexin
Dosage form CAPSULE
Route ORAL
Labeler Preferred Pharmaceuticals, Inc.
Application ANDA062791
Marketing category ANDA
Marketing start 2010-06-21
Marketing end 0000-00-00
Substance CEPHALEXIN
Active strength 500 mg/1
Pharmacologic classes Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 3 · 176 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A062791-001 CEPHALEXIN CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 A062791-002 CEPHALEXIN CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A062791-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL 1987-06-11 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A062791-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL 1987-06-11 782e0a99824c…
Observed Orange Book normalized TE history# DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Related label table NDC Related label 68788-9752-1 Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. 68788-9752-2 Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. 68788-9752-3 Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. 68788-9752-4 Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. 68788-9752-6 Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. 68788-9752-7 Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. 68788-9752-8 Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
DailyMed Package Descriptions# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CEPHALEXIN ACTIVE INGREDIENT OBN7UDS42Y CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 3 CEPHALEXIN ANHYDROUS ACTIVE MOIETY 5SFF1W6677 CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 3 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 3 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 3 FD&C GREEN NO. 3 INACTIVE INGREDIENT 3P3ONR6O1S CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 3 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 3 GELATIN INACTIVE INGREDIENT 2G86QN327L CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 3 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 3 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 3 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68788-9752 CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] 3 Legacy NDC, 7 package rows 20141008_981e3b45-0fd0-4198-a6e0-fead314c85a9.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 68788-9752-1 68788975201 12 in 1 BOTTLE Historical 68788-9752-2 68788975202 20 in 1 BOTTLE Historical 68788-9752-3 68788975203 30 in 1 BOTTLE Historical 68788-9752-4 68788975204 40 in 1 BOTTLE Historical 68788-9752-6 68788975206 60 in 1 BOTTLE Historical 68788-9752-7 68788975207 21 in 1 BOTTLE Historical 68788-9752-8 68788975208 28 in 1 BOTTLE Historical